SR One

We are on a mission to translate ground-breaking science into next generation medicines

Our portfolio companies are re-writing the medical textbooks, turning truly innovative discoveries into transformational new therapies Across key disease areas and modalities, innovation is in our DNA

We are patient-focused, dedicated to addressing unmet clinical needs

There remain major gaps in therapeutic options across oncology, immunology, rare and other diseases At SR One, we believe that singular focus on closing these gaps enables our portfolio companies to create new paradigms in medicine

Our Trans-Atlantic presence enables us to access top science across geographies

SR One’s investing team is situated in key biotech hubs on the West and East Coast, USA and London, UK We are an integrated part of these vibrant ecosystems, dedicated to venture creation since 1985